BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35896240)

  • 1. MR Prediction of Malignant Switch With the Cyst Fluid's T2 Value in Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Preliminary Study.
    Takao S; Nishie A; Ushijima Y; Takayama Y; Morita K; Ishimatsu K; Koga Y; Mori Y; Akamine Y; Ishigami K
    Anticancer Res; 2022 Aug; 42(8):3895-3903. PubMed ID: 35896240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
    Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
    Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
    Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
    Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of 3-T MR imaging in intraductal papillary mucinous neoplasm with a concomitant invasive carcinoma.
    Sotozono H; Kanki A; Yasokawa K; Yamamoto A; Sanai H; Moriya K; Tamada T
    Eur Radiol; 2022 Dec; 32(12):8276-8284. PubMed ID: 35665843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
    Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
    Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
    Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
    AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F
    Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT and MR imaging features of fistulas from intraductal papillary mucinous neoplasms of the pancreas to adjacent organs: A retrospective study of 423 patients.
    Ravaud S; Laurent V; Jausset F; Cannard L; Mandry D; Oliver A; Claudon M
    Eur J Radiol; 2015 Nov; 84(11):2080-8. PubMed ID: 26321495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
    Raman SP; Kawamoto S; Blackford A; Hruban RH; Lennon AM; Wolfgang CL; Rezaee N; Edil B; Fishman EK
    AJR Am J Roentgenol; 2013 Mar; 200(3):563-9. PubMed ID: 23436845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
    Munigala S; Javia SB; Agarwal B
    Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.
    Maker AV; Hu V; Kadkol SS; Hong L; Brugge W; Winter J; Yeo CJ; Hackert T; Büchler M; Lawlor RT; Salvia R; Scarpa A; Bassi C; Green S
    J Am Coll Surg; 2019 May; 228(5):721-729. PubMed ID: 30794864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E
    Yip-Schneider MT; Carr RA; Wu H; Schmidt CM
    J Am Coll Surg; 2017 Oct; 225(4):481-487. PubMed ID: 28739154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas using MR findings and texture analysis.
    Jeon SK; Kim JH; Yoo J; Kim JE; Park SJ; Han JK
    Eur Radiol; 2021 May; 31(5):3394-3404. PubMed ID: 33140171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation.
    D'Onofrio M; Tedesco G; Cardobi N; De Robertis R; Sarno A; Capelli P; Martini PT; Giannotti G; Beleù A; Marchegiani G; Gobbo S; Butturini G; Bogdan M; Salvia R; Bassi C
    Pancreatology; 2021 Jan; 21(1):180-187. PubMed ID: 33376061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.